Global Mirabegron Drugs Market Growth 2026-2032
The global Mirabegron Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Mirabegron is a beta-3 adrenergic agonist which is used to manage symptoms of overactive bladder (OAB), such as frequent urination, urgency, and urinary incontinence.
United States market for Mirabegron Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Mirabegron Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Mirabegron Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Mirabegron Drugs players cover Astellas Pharma, Zydus Lifesciences, Lupin Pharmaceuticals, Alkem Laboratories, Chia Tai Tianqing Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Mirabegron Drugs Industry Forecast? looks at past sales and reviews total world Mirabegron Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Mirabegron Drugs sales for 2026 through 2032. With Mirabegron Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mirabegron Drugs industry.
This Insight Report provides a comprehensive analysis of the global Mirabegron Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mirabegron Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mirabegron Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mirabegron Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mirabegron Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Mirabegron Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mirabegron Drugs market?
What factors are driving Mirabegron Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mirabegron Drugs market opportunities vary by end market size?
How does Mirabegron Drugs break out by Type, by Application?
Mirabegron is a beta-3 adrenergic agonist which is used to manage symptoms of overactive bladder (OAB), such as frequent urination, urgency, and urinary incontinence.
United States market for Mirabegron Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Mirabegron Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Mirabegron Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Mirabegron Drugs players cover Astellas Pharma, Zydus Lifesciences, Lupin Pharmaceuticals, Alkem Laboratories, Chia Tai Tianqing Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Mirabegron Drugs Industry Forecast? looks at past sales and reviews total world Mirabegron Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Mirabegron Drugs sales for 2026 through 2032. With Mirabegron Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mirabegron Drugs industry.
This Insight Report provides a comprehensive analysis of the global Mirabegron Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mirabegron Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mirabegron Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mirabegron Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mirabegron Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Mirabegron Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Extended-release Tablet
- Oral Suspension
- Urgency
- Frequent Urination
- Urine Leakage
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas Pharma
- Zydus Lifesciences
- Lupin Pharmaceuticals
- Alkem Laboratories
- Chia Tai Tianqing Pharmaceutical
- Zhejiang Huayi Pharmaceutical
- China Resources Pharmaceutical
- Jiangxi Shanxiang Pharmaceutical
- CSPC Pharmaceutical
- Qilu Pharmaceutical
- Jiangsu Huayang Pharmaceutical
- Sichuan Gowell Pharmaceutical
- Shenzhen Main Luck Pharmaceuticals
What is the 10-year outlook for the global Mirabegron Drugs market?
What factors are driving Mirabegron Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mirabegron Drugs market opportunities vary by end market size?
How does Mirabegron Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mirabegron Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mirabegron Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mirabegron Drugs by Country/Region, 2021, 2025 & 2032
2.2 Mirabegron Drugs Segment by Type
2.2.1 Extended-release Tablet
2.2.2 Oral Suspension
2.2.3 Mirabegron Drugs Sales by Type
2.2.3.1 Global Mirabegron Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Mirabegron Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Mirabegron Drugs Sale Price by Type (2021-2026)
2.3 Mirabegron Drugs Segment by Application
2.3.1 Urgency
2.3.2 Frequent Urination
2.3.3 Urine Leakage
2.3.4 Other
2.3.5 Mirabegron Drugs Sales by Application
2.3.5.1 Global Mirabegron Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Mirabegron Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Mirabegron Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mirabegron Drugs Breakdown Data by Company
3.1.1 Global Mirabegron Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Mirabegron Drugs Sales Market Share by Company (2021-2026)
3.2 Global Mirabegron Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Mirabegron Drugs Revenue by Company (2021-2026)
3.2.2 Global Mirabegron Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Mirabegron Drugs Sale Price by Company
3.4 Key Manufacturers Mirabegron Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mirabegron Drugs Product Location Distribution
3.4.2 Players Mirabegron Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MIRABEGRON DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Mirabegron Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Mirabegron Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mirabegron Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mirabegron Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Mirabegron Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mirabegron Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mirabegron Drugs Sales Growth
4.4 APAC Mirabegron Drugs Sales Growth
4.5 Europe Mirabegron Drugs Sales Growth
4.6 Middle East & Africa Mirabegron Drugs Sales Growth
5 AMERICAS
5.1 Americas Mirabegron Drugs Sales by Country
5.1.1 Americas Mirabegron Drugs Sales by Country (2021-2026)
5.1.2 Americas Mirabegron Drugs Revenue by Country (2021-2026)
5.2 Americas Mirabegron Drugs Sales by Type (2021-2026)
5.3 Americas Mirabegron Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mirabegron Drugs Sales by Region
6.1.1 APAC Mirabegron Drugs Sales by Region (2021-2026)
6.1.2 APAC Mirabegron Drugs Revenue by Region (2021-2026)
6.2 APAC Mirabegron Drugs Sales by Type (2021-2026)
6.3 APAC Mirabegron Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mirabegron Drugs by Country
7.1.1 Europe Mirabegron Drugs Sales by Country (2021-2026)
7.1.2 Europe Mirabegron Drugs Revenue by Country (2021-2026)
7.2 Europe Mirabegron Drugs Sales by Type (2021-2026)
7.3 Europe Mirabegron Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mirabegron Drugs by Country
8.1.1 Middle East & Africa Mirabegron Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mirabegron Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Mirabegron Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Mirabegron Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mirabegron Drugs
10.3 Manufacturing Process Analysis of Mirabegron Drugs
10.4 Industry Chain Structure of Mirabegron Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mirabegron Drugs Distributors
11.3 Mirabegron Drugs Customer
12 WORLD FORECAST REVIEW FOR MIRABEGRON DRUGS BY GEOGRAPHIC REGION
12.1 Global Mirabegron Drugs Market Size Forecast by Region
12.1.1 Global Mirabegron Drugs Forecast by Region (2027-2032)
12.1.2 Global Mirabegron Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mirabegron Drugs Forecast by Type (2027-2032)
12.7 Global Mirabegron Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Information
13.1.2 Astellas Pharma Mirabegron Drugs Product Portfolios and Specifications
13.1.3 Astellas Pharma Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Pharma Main Business Overview
13.1.5 Astellas Pharma Latest Developments
13.2 Zydus Lifesciences
13.2.1 Zydus Lifesciences Company Information
13.2.2 Zydus Lifesciences Mirabegron Drugs Product Portfolios and Specifications
13.2.3 Zydus Lifesciences Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zydus Lifesciences Main Business Overview
13.2.5 Zydus Lifesciences Latest Developments
13.3 Lupin Pharmaceuticals
13.3.1 Lupin Pharmaceuticals Company Information
13.3.2 Lupin Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
13.3.3 Lupin Pharmaceuticals Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lupin Pharmaceuticals Main Business Overview
13.3.5 Lupin Pharmaceuticals Latest Developments
13.4 Alkem Laboratories
13.4.1 Alkem Laboratories Company Information
13.4.2 Alkem Laboratories Mirabegron Drugs Product Portfolios and Specifications
13.4.3 Alkem Laboratories Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Alkem Laboratories Main Business Overview
13.4.5 Alkem Laboratories Latest Developments
13.5 Chia Tai Tianqing Pharmaceutical
13.5.1 Chia Tai Tianqing Pharmaceutical Company Information
13.5.2 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.5.3 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.5.5 Chia Tai Tianqing Pharmaceutical Latest Developments
13.6 Zhejiang Huayi Pharmaceutical
13.6.1 Zhejiang Huayi Pharmaceutical Company Information
13.6.2 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.6.3 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Zhejiang Huayi Pharmaceutical Main Business Overview
13.6.5 Zhejiang Huayi Pharmaceutical Latest Developments
13.7 China Resources Pharmaceutical
13.7.1 China Resources Pharmaceutical Company Information
13.7.2 China Resources Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.7.3 China Resources Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China Resources Pharmaceutical Main Business Overview
13.7.5 China Resources Pharmaceutical Latest Developments
13.8 Jiangxi Shanxiang Pharmaceutical
13.8.1 Jiangxi Shanxiang Pharmaceutical Company Information
13.8.2 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.8.3 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jiangxi Shanxiang Pharmaceutical Main Business Overview
13.8.5 Jiangxi Shanxiang Pharmaceutical Latest Developments
13.9 CSPC Pharmaceutical
13.9.1 CSPC Pharmaceutical Company Information
13.9.2 CSPC Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.9.3 CSPC Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CSPC Pharmaceutical Main Business Overview
13.9.5 CSPC Pharmaceutical Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Jiangsu Huayang Pharmaceutical
13.11.1 Jiangsu Huayang Pharmaceutical Company Information
13.11.2 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.11.3 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Huayang Pharmaceutical Main Business Overview
13.11.5 Jiangsu Huayang Pharmaceutical Latest Developments
13.12 Sichuan Gowell Pharmaceutical
13.12.1 Sichuan Gowell Pharmaceutical Company Information
13.12.2 Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.12.3 Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sichuan Gowell Pharmaceutical Main Business Overview
13.12.5 Sichuan Gowell Pharmaceutical Latest Developments
13.13 Shenzhen Main Luck Pharmaceuticals
13.13.1 Shenzhen Main Luck Pharmaceuticals Company Information
13.13.2 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
13.13.3 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shenzhen Main Luck Pharmaceuticals Main Business Overview
13.13.5 Shenzhen Main Luck Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mirabegron Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mirabegron Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mirabegron Drugs by Country/Region, 2021, 2025 & 2032
2.2 Mirabegron Drugs Segment by Type
2.2.1 Extended-release Tablet
2.2.2 Oral Suspension
2.2.3 Mirabegron Drugs Sales by Type
2.2.3.1 Global Mirabegron Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Mirabegron Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Mirabegron Drugs Sale Price by Type (2021-2026)
2.3 Mirabegron Drugs Segment by Application
2.3.1 Urgency
2.3.2 Frequent Urination
2.3.3 Urine Leakage
2.3.4 Other
2.3.5 Mirabegron Drugs Sales by Application
2.3.5.1 Global Mirabegron Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Mirabegron Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Mirabegron Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mirabegron Drugs Breakdown Data by Company
3.1.1 Global Mirabegron Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Mirabegron Drugs Sales Market Share by Company (2021-2026)
3.2 Global Mirabegron Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Mirabegron Drugs Revenue by Company (2021-2026)
3.2.2 Global Mirabegron Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Mirabegron Drugs Sale Price by Company
3.4 Key Manufacturers Mirabegron Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mirabegron Drugs Product Location Distribution
3.4.2 Players Mirabegron Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MIRABEGRON DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Mirabegron Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Mirabegron Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mirabegron Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mirabegron Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Mirabegron Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mirabegron Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mirabegron Drugs Sales Growth
4.4 APAC Mirabegron Drugs Sales Growth
4.5 Europe Mirabegron Drugs Sales Growth
4.6 Middle East & Africa Mirabegron Drugs Sales Growth
5 AMERICAS
5.1 Americas Mirabegron Drugs Sales by Country
5.1.1 Americas Mirabegron Drugs Sales by Country (2021-2026)
5.1.2 Americas Mirabegron Drugs Revenue by Country (2021-2026)
5.2 Americas Mirabegron Drugs Sales by Type (2021-2026)
5.3 Americas Mirabegron Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mirabegron Drugs Sales by Region
6.1.1 APAC Mirabegron Drugs Sales by Region (2021-2026)
6.1.2 APAC Mirabegron Drugs Revenue by Region (2021-2026)
6.2 APAC Mirabegron Drugs Sales by Type (2021-2026)
6.3 APAC Mirabegron Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mirabegron Drugs by Country
7.1.1 Europe Mirabegron Drugs Sales by Country (2021-2026)
7.1.2 Europe Mirabegron Drugs Revenue by Country (2021-2026)
7.2 Europe Mirabegron Drugs Sales by Type (2021-2026)
7.3 Europe Mirabegron Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mirabegron Drugs by Country
8.1.1 Middle East & Africa Mirabegron Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mirabegron Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Mirabegron Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Mirabegron Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mirabegron Drugs
10.3 Manufacturing Process Analysis of Mirabegron Drugs
10.4 Industry Chain Structure of Mirabegron Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mirabegron Drugs Distributors
11.3 Mirabegron Drugs Customer
12 WORLD FORECAST REVIEW FOR MIRABEGRON DRUGS BY GEOGRAPHIC REGION
12.1 Global Mirabegron Drugs Market Size Forecast by Region
12.1.1 Global Mirabegron Drugs Forecast by Region (2027-2032)
12.1.2 Global Mirabegron Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mirabegron Drugs Forecast by Type (2027-2032)
12.7 Global Mirabegron Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Information
13.1.2 Astellas Pharma Mirabegron Drugs Product Portfolios and Specifications
13.1.3 Astellas Pharma Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Pharma Main Business Overview
13.1.5 Astellas Pharma Latest Developments
13.2 Zydus Lifesciences
13.2.1 Zydus Lifesciences Company Information
13.2.2 Zydus Lifesciences Mirabegron Drugs Product Portfolios and Specifications
13.2.3 Zydus Lifesciences Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zydus Lifesciences Main Business Overview
13.2.5 Zydus Lifesciences Latest Developments
13.3 Lupin Pharmaceuticals
13.3.1 Lupin Pharmaceuticals Company Information
13.3.2 Lupin Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
13.3.3 Lupin Pharmaceuticals Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lupin Pharmaceuticals Main Business Overview
13.3.5 Lupin Pharmaceuticals Latest Developments
13.4 Alkem Laboratories
13.4.1 Alkem Laboratories Company Information
13.4.2 Alkem Laboratories Mirabegron Drugs Product Portfolios and Specifications
13.4.3 Alkem Laboratories Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Alkem Laboratories Main Business Overview
13.4.5 Alkem Laboratories Latest Developments
13.5 Chia Tai Tianqing Pharmaceutical
13.5.1 Chia Tai Tianqing Pharmaceutical Company Information
13.5.2 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.5.3 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.5.5 Chia Tai Tianqing Pharmaceutical Latest Developments
13.6 Zhejiang Huayi Pharmaceutical
13.6.1 Zhejiang Huayi Pharmaceutical Company Information
13.6.2 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.6.3 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Zhejiang Huayi Pharmaceutical Main Business Overview
13.6.5 Zhejiang Huayi Pharmaceutical Latest Developments
13.7 China Resources Pharmaceutical
13.7.1 China Resources Pharmaceutical Company Information
13.7.2 China Resources Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.7.3 China Resources Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China Resources Pharmaceutical Main Business Overview
13.7.5 China Resources Pharmaceutical Latest Developments
13.8 Jiangxi Shanxiang Pharmaceutical
13.8.1 Jiangxi Shanxiang Pharmaceutical Company Information
13.8.2 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.8.3 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jiangxi Shanxiang Pharmaceutical Main Business Overview
13.8.5 Jiangxi Shanxiang Pharmaceutical Latest Developments
13.9 CSPC Pharmaceutical
13.9.1 CSPC Pharmaceutical Company Information
13.9.2 CSPC Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.9.3 CSPC Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CSPC Pharmaceutical Main Business Overview
13.9.5 CSPC Pharmaceutical Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Jiangsu Huayang Pharmaceutical
13.11.1 Jiangsu Huayang Pharmaceutical Company Information
13.11.2 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.11.3 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Huayang Pharmaceutical Main Business Overview
13.11.5 Jiangsu Huayang Pharmaceutical Latest Developments
13.12 Sichuan Gowell Pharmaceutical
13.12.1 Sichuan Gowell Pharmaceutical Company Information
13.12.2 Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
13.12.3 Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sichuan Gowell Pharmaceutical Main Business Overview
13.12.5 Sichuan Gowell Pharmaceutical Latest Developments
13.13 Shenzhen Main Luck Pharmaceuticals
13.13.1 Shenzhen Main Luck Pharmaceuticals Company Information
13.13.2 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
13.13.3 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shenzhen Main Luck Pharmaceuticals Main Business Overview
13.13.5 Shenzhen Main Luck Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mirabegron Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mirabegron Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Extended-releaseTablet
Table 4. Major Players of Oral Suspension
Table 5. Global Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Mirabegron Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Mirabegron Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mirabegron Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Mirabegron Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Mirabegron Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Mirabegron Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Mirabegron Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Mirabegron Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Mirabegron Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Mirabegron Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Mirabegron Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Mirabegron Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Mirabegron Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Mirabegron Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Mirabegron Drugs Producing Area Distribution and Sales Area
Table 21. Players Mirabegron Drugs Products Offered
Table 22. Mirabegron Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Mirabegron Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Mirabegron Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Mirabegron Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Mirabegron Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Mirabegron Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Mirabegron Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Mirabegron Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Mirabegron Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Mirabegron Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Mirabegron Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Mirabegron Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Mirabegron Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Mirabegron Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Mirabegron Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Mirabegron Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Mirabegron Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Mirabegron Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Mirabegron Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Mirabegron Drugs
Table 52. Key Market Challenges & Risks of Mirabegron Drugs
Table 53. Key Industry Trends of Mirabegron Drugs
Table 54. Mirabegron Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Mirabegron Drugs Distributors List
Table 57. Mirabegron Drugs Customer List
Table 58. Global Mirabegron Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Mirabegron Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Mirabegron Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Mirabegron Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Mirabegron Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Mirabegron Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Mirabegron Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Mirabegron Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Mirabegron Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Mirabegron Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Mirabegron Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Mirabegron Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Mirabegron Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Mirabegron Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Mirabegron Drugs Product Portfolios and Specifications
Table 74. Astellas Pharma Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Zydus Lifesciences Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Zydus Lifesciences Mirabegron Drugs Product Portfolios and Specifications
Table 79. Zydus Lifesciences Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zydus Lifesciences Main Business
Table 81. Zydus Lifesciences Latest Developments
Table 82. Lupin Pharmaceuticals Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Lupin Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
Table 84. Lupin Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Lupin Pharmaceuticals Main Business
Table 86. Lupin Pharmaceuticals Latest Developments
Table 87. Alkem Laboratories Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Alkem Laboratories Mirabegron Drugs Product Portfolios and Specifications
Table 89. Alkem Laboratories Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Alkem Laboratories Main Business
Table 91. Alkem Laboratories Latest Developments
Table 92. Chia Tai Tianqing Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 94. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Chia Tai Tianqing Pharmaceutical Main Business
Table 96. Chia Tai Tianqing Pharmaceutical Latest Developments
Table 97. Zhejiang Huayi Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 99. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Zhejiang Huayi Pharmaceutical Main Business
Table 101. Zhejiang Huayi Pharmaceutical Latest Developments
Table 102. China Resources Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. China Resources Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 104. China Resources Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. China Resources Pharmaceutical Main Business
Table 106. China Resources Pharmaceutical Latest Developments
Table 107. Jiangxi Shanxiang Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 109. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Jiangxi Shanxiang Pharmaceutical Main Business
Table 111. Jiangxi Shanxiang Pharmaceutical Latest Developments
Table 112. CSPC Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. CSPC Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 114. CSPC Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. CSPC Pharmaceutical Main Business
Table 116. CSPC Pharmaceutical Latest Developments
Table 117. Qilu Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Qilu Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 119. Qilu Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Qilu Pharmaceutical Main Business
Table 121. Qilu Pharmaceutical Latest Developments
Table 122. Jiangsu Huayang Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 124. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jiangsu Huayang Pharmaceutical Main Business
Table 126. Jiangsu Huayang Pharmaceutical Latest Developments
Table 127. Sichuan Gowell Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 129. Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Sichuan Gowell Pharmaceutical Main Business
Table 131. Sichuan Gowell Pharmaceutical Latest Developments
Table 132. Shenzhen Main Luck Pharmaceuticals Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
Table 134. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shenzhen Main Luck Pharmaceuticals Main Business
Table 136. Shenzhen Main Luck Pharmaceuticals Latest Developments
Table 1. Mirabegron Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mirabegron Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Extended-releaseTablet
Table 4. Major Players of Oral Suspension
Table 5. Global Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Mirabegron Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Mirabegron Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mirabegron Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Mirabegron Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Mirabegron Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Mirabegron Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Mirabegron Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Mirabegron Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Mirabegron Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Mirabegron Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Mirabegron Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Mirabegron Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Mirabegron Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Mirabegron Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Mirabegron Drugs Producing Area Distribution and Sales Area
Table 21. Players Mirabegron Drugs Products Offered
Table 22. Mirabegron Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Mirabegron Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Mirabegron Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Mirabegron Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Mirabegron Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Mirabegron Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Mirabegron Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Mirabegron Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Mirabegron Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Mirabegron Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Mirabegron Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Mirabegron Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Mirabegron Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Mirabegron Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Mirabegron Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Mirabegron Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Mirabegron Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Mirabegron Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Mirabegron Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Mirabegron Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Mirabegron Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Mirabegron Drugs
Table 52. Key Market Challenges & Risks of Mirabegron Drugs
Table 53. Key Industry Trends of Mirabegron Drugs
Table 54. Mirabegron Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Mirabegron Drugs Distributors List
Table 57. Mirabegron Drugs Customer List
Table 58. Global Mirabegron Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Mirabegron Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Mirabegron Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Mirabegron Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Mirabegron Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Mirabegron Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Mirabegron Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Mirabegron Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Mirabegron Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Mirabegron Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Mirabegron Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Mirabegron Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Mirabegron Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Mirabegron Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Mirabegron Drugs Product Portfolios and Specifications
Table 74. Astellas Pharma Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Zydus Lifesciences Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Zydus Lifesciences Mirabegron Drugs Product Portfolios and Specifications
Table 79. Zydus Lifesciences Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zydus Lifesciences Main Business
Table 81. Zydus Lifesciences Latest Developments
Table 82. Lupin Pharmaceuticals Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Lupin Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
Table 84. Lupin Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Lupin Pharmaceuticals Main Business
Table 86. Lupin Pharmaceuticals Latest Developments
Table 87. Alkem Laboratories Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Alkem Laboratories Mirabegron Drugs Product Portfolios and Specifications
Table 89. Alkem Laboratories Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Alkem Laboratories Main Business
Table 91. Alkem Laboratories Latest Developments
Table 92. Chia Tai Tianqing Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 94. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Chia Tai Tianqing Pharmaceutical Main Business
Table 96. Chia Tai Tianqing Pharmaceutical Latest Developments
Table 97. Zhejiang Huayi Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 99. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Zhejiang Huayi Pharmaceutical Main Business
Table 101. Zhejiang Huayi Pharmaceutical Latest Developments
Table 102. China Resources Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. China Resources Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 104. China Resources Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. China Resources Pharmaceutical Main Business
Table 106. China Resources Pharmaceutical Latest Developments
Table 107. Jiangxi Shanxiang Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 109. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Jiangxi Shanxiang Pharmaceutical Main Business
Table 111. Jiangxi Shanxiang Pharmaceutical Latest Developments
Table 112. CSPC Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. CSPC Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 114. CSPC Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. CSPC Pharmaceutical Main Business
Table 116. CSPC Pharmaceutical Latest Developments
Table 117. Qilu Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Qilu Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 119. Qilu Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Qilu Pharmaceutical Main Business
Table 121. Qilu Pharmaceutical Latest Developments
Table 122. Jiangsu Huayang Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 124. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jiangsu Huayang Pharmaceutical Main Business
Table 126. Jiangsu Huayang Pharmaceutical Latest Developments
Table 127. Sichuan Gowell Pharmaceutical Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolios and Specifications
Table 129. Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Sichuan Gowell Pharmaceutical Main Business
Table 131. Sichuan Gowell Pharmaceutical Latest Developments
Table 132. Shenzhen Main Luck Pharmaceuticals Basic Information, Mirabegron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolios and Specifications
Table 134. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shenzhen Main Luck Pharmaceuticals Main Business
Table 136. Shenzhen Main Luck Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mirabegron Drugs
Figure 2. Mirabegron Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mirabegron Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Mirabegron Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mirabegron Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mirabegron Drugs Sales Market Share by Country/Region (2025)
Figure 10. Mirabegron Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Extended-releaseTablet
Figure 12. Product Picture of Oral Suspension
Figure 13. Global Mirabegron Drugs Sales Market Share by Type in 2026
Figure 14. Global Mirabegron Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Mirabegron Drugs Consumed in Urgency
Figure 16. Global Mirabegron Drugs Market: Urgency (2021-2026) & (K Units)
Figure 17. Mirabegron Drugs Consumed in Frequent Urination
Figure 18. Global Mirabegron Drugs Market: Frequent Urination (2021-2026) & (K Units)
Figure 19. Mirabegron Drugs Consumed in Urine Leakage
Figure 20. Global Mirabegron Drugs Market: Urine Leakage (2021-2026) & (K Units)
Figure 21. Mirabegron Drugs Consumed in Other
Figure 22. Global Mirabegron Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Mirabegron Drugs Sale Market Share by Application (2025)
Figure 24. Global Mirabegron Drugs Revenue Market Share by Application in 2026
Figure 25. Mirabegron Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Mirabegron Drugs Sales Market Share by Company in 2026
Figure 27. Mirabegron Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Mirabegron Drugs Revenue Market Share by Company in 2026
Figure 29. Global Mirabegron Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Mirabegron Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Mirabegron Drugs Sales Market Share by Country in 2026
Figure 40. Americas Mirabegron Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Mirabegron Drugs Sales Market Share by Region in 2026
Figure 48. APAC Mirabegron Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Mirabegron Drugs Sales Market Share by Country in 2026
Figure 59. Europe Mirabegron Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Mirabegron Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Mirabegron Drugs in 2026
Figure 76. Manufacturing Process Analysis of Mirabegron Drugs
Figure 77. Industry Chain Structure of Mirabegron Drugs
Figure 78. Channels of Distribution
Figure 79. Global Mirabegron Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Mirabegron Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Mirabegron Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Mirabegron Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Mirabegron Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Mirabegron Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Mirabegron Drugs
Figure 2. Mirabegron Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mirabegron Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Mirabegron Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mirabegron Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mirabegron Drugs Sales Market Share by Country/Region (2025)
Figure 10. Mirabegron Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Extended-releaseTablet
Figure 12. Product Picture of Oral Suspension
Figure 13. Global Mirabegron Drugs Sales Market Share by Type in 2026
Figure 14. Global Mirabegron Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Mirabegron Drugs Consumed in Urgency
Figure 16. Global Mirabegron Drugs Market: Urgency (2021-2026) & (K Units)
Figure 17. Mirabegron Drugs Consumed in Frequent Urination
Figure 18. Global Mirabegron Drugs Market: Frequent Urination (2021-2026) & (K Units)
Figure 19. Mirabegron Drugs Consumed in Urine Leakage
Figure 20. Global Mirabegron Drugs Market: Urine Leakage (2021-2026) & (K Units)
Figure 21. Mirabegron Drugs Consumed in Other
Figure 22. Global Mirabegron Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Mirabegron Drugs Sale Market Share by Application (2025)
Figure 24. Global Mirabegron Drugs Revenue Market Share by Application in 2026
Figure 25. Mirabegron Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Mirabegron Drugs Sales Market Share by Company in 2026
Figure 27. Mirabegron Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Mirabegron Drugs Revenue Market Share by Company in 2026
Figure 29. Global Mirabegron Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Mirabegron Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Mirabegron Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Mirabegron Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Mirabegron Drugs Sales Market Share by Country in 2026
Figure 40. Americas Mirabegron Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Mirabegron Drugs Sales Market Share by Region in 2026
Figure 48. APAC Mirabegron Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Mirabegron Drugs Sales Market Share by Country in 2026
Figure 59. Europe Mirabegron Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Mirabegron Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Mirabegron Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Mirabegron Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Mirabegron Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Mirabegron Drugs in 2026
Figure 76. Manufacturing Process Analysis of Mirabegron Drugs
Figure 77. Industry Chain Structure of Mirabegron Drugs
Figure 78. Channels of Distribution
Figure 79. Global Mirabegron Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Mirabegron Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Mirabegron Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Mirabegron Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Mirabegron Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Mirabegron Drugs Revenue Market Share Forecast by Application (2027-2032)
